| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.0035 | 1 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |